基于 3 个已确定 T+90 收益的买入信号。收益基准:公布次日的收盘价。
Browse the complete record of transactions filed by Cochran Jennifer R., 董事. Officer active across 2 companies, notably Ligand Pharmaceuticals INC. Cumulatively, 14 disclosures have been published. Breakdown: 3 buys · 0 sell. Total volume traded: €211k. Activity tracked since 12 July 2021. The latest transaction was disclosed on 15 May 2025 (Acquisition). Regulator: SEC (Form 4). All data is accessible without signup.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
14 条申报中的 14 条
Cochran Jennifer R. is Administrateur at OmniAb, Inc. and is also linked to Ligand Pharmaceuticals INC. There are 14 filings in total, and across the sampled recent filings from 2021-07-14 to 2026-06-18, buys amount to EUR 211489, with no sells reported. The most common transaction nature is option exercise.